Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 38 results for "sanofi"

Sanofi India elevates N. Rajaram as Managing Director
Afaqs

Sanofi India elevates N. Rajaram as Managing Director

The appointment will be effective from January 1, 2018. In a recent announcement, pharma company Sanofi India, has elevated N. Rajaram as managing director. The new role will be effective from January 1, 2018. Rajaram joined the company in January 2014 and ... Afaqs, 1 month ago
Volumes jump at Sanofi India counter Business Standard, 2 months ago

5 images for sanofi

Business Standard, 2 days ago
Business Standard, 1 week ago
Afaqs, 1 month ago
Money Control, 4 months ago
Money Control, 6 months ago
Rediff.com

How India narrowly escaped a health crisis

The Philippines launches probe after Sanofi reveals WHO-approved dengvaxia - a dengue vaccine - aggravates symptoms in some cases. The delay by the health ministry in approving the sale of the first-ever dengue vaccine developed by French pharmaceutical major Sanofi Pasteur might seem like another case of red tape, but the health crisis unfolding in the Philippines shows that India might have narrowly avoided a disaster.   The World Health Organization (WHO) had approved ...
 Rediff.com1 month ago How red tape over a dengue vaccine avoided a health crisis  Business Standard1 month ago

Letters: Unwitting savior

Only a total ban on Sanofi and summary dismissal of all those concerned with the matter at WHO might meet the demands of social justice
 Business Standard1 month ago

Trouble mounts for Sanofi dengue vaccine over safety concerns | Reuters

(Reuters) - The World Health Organization said on Monday it hopes to review safety data on Sanofi’s dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization program after the French drugmaker said ...
 First Post.com1 month ago WHO reviewing data on Sanofi dengue vaccine, urges limited use  Reuters1 month ago Sanofi expects $120 million hit as dengue vaccine hits major snag  Reuters1 month ago

Sanofi India spurts after unveiling Q2 earnings

after the company reported an impressive growth in bottom line in Q2 September 2017. Meanwhile, the S BSE Sensex was up 416.81 points or 1.25% at 33,629.94. On the BSE, 4,787 shares were traded on the counter so far as against average daily volumes of 148 ...
 Business Standard2 months ago

Sanofi India standalone net profit rises 40.29% in the September 2017 quarter

Sales rise 4.99% to Rs 626.60 crore Net profit of Sanofi India rose 40.29% to Rs 116.30 crore in the quarter ended September 2017 as against Rs 82.90 crore during the previous quarter ended September 2016. Sales rose 4.99% to Rs 626.60 crore in the quarter ...
 Business Standard2 months ago

Sanofi and Regeneron boost investment in cancer drug cemiplimab

PARIS (Reuters) - France's Sanofi and U.S Regeneron said on Monday they would inject an additional $1 billion in the development of cemiplimab, an antibody that could, if successful, be used to treat a wide range of cancers.
 Reuters2 weeks ago Sanofi investors hungry for drug progress and deal news  Reuters1 month ago

Philippines fines Sanofi, suspends clearance for Dengvaxia

MANILA (Reuters) - The Philippines has suspended clearance for Sanofi's dengue vaccine Dengvaxia and fined the French drugmaker a symbolic $2,000 citing violations on product registration and marketing, the health secretary said on Thursday.
 Reuters2 weeks ago Philippines to seek refund of $59 million from Sanofi amid vaccine risk  Reuters1 month ago Philippines halts sale of dengue vaccine as Sanofi downplays risk  Reuters1 month ago

France's Sanofi pins hopes on new drugs after setbacks

PARIS (Reuters) - Sanofi's promising pipeline of experimental drugs can help it overcome setbacks including the low uptake of a new cholesterol treatment and concerns about a dengue vaccine, the French pharmaceuticals group said on Wednesday.
 Reuters1 month ago

Sanofi sees nine regulatory submissions over next 18 months

PARIS (Reuters) - Sanofi said on Wednesday it expected to file nine regulatory submissions for new drugs over the next 18 months and that its pipeline of new products would support long-term growth.
 Reuters1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less